These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9234177)

  • 1. Stem cell mobilization in normal donors.
    Tabilio A; Falzetti F; Giannoni C; Aversa F; Martelli MP; Rossetti M; Caputo P; Chionne F; Gambelunghe C; Martelli MF
    J Hematother; 1997 Jun; 6(3):227-34. PubMed ID: 9234177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of short G-CSF administration on the numbers and clonogenic efficiency of hematopoietic progenitor cells in bone marrow and peripheral blood of normal donors.
    Zaucha JM; Knopińska-Posłuszny W; Bieniaszewska M; Myśliwski A; Hellmann A
    Ann Transplant; 2000; 5(4):20-6. PubMed ID: 11499355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rhG-CSF in healthy donors: mobilization of peripheral hemopoietic progenitors and effect on peripheral blood leukocytes.
    Sica S; Rutella S; Di Mario A; Salutari P; Rumi C; Ortu la Barbera E; Etuk B; Menichella G; D'Onofrio G; Leone G
    J Hematother; 1996 Aug; 5(4):391-7. PubMed ID: 8877714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors affecting mobilization of peripheral blood stem/progenitor cells and apheresis efficiency from healthy donors by rhG-CSF].
    Liang ZY; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):847-51. PubMed ID: 18718074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation.
    Lane TA; Law P; Maruyama M; Young D; Burgess J; Mullen M; Mealiffe M; Terstappen LW; Hardwick A; Moubayed M
    Blood; 1995 Jan; 85(1):275-82. PubMed ID: 7528570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both.
    Ho AD; Young D; Maruyama M; Corringham RE; Mason JR; Thompson P; Grenier K; Law P; Terstappen LW; Lane T
    Exp Hematol; 1996 Nov; 24(13):1460-8. PubMed ID: 8950228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential changes in stem cell markers in peripheral blood and leukapheresis samples after injections of recombinant human granulocyte colony-stimulating factor in patients with urogenital malignant solid tumors: a preliminary study.
    Samma S; Momose H; Ozono S; Hirao Y; Okajima E; Morii T; Nishikawa K; Shimoyama T; Fujimura Y
    Jpn J Clin Oncol; 1994 Oct; 24(5):269-74. PubMed ID: 7526017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients.
    Meehan KR; Slack R; Gehan E; Herscowitz HB; Areman EM; Ebadi M; Cairo MS; Lippman ME
    J Hematother Stem Cell Res; 2002 Apr; 11(2):415-21. PubMed ID: 11983113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
    Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M
    Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of peripheral blood stem cell collection in large-volume leukapheresis for pediatric patients undergoing chemotherapy and adult patients before chemotherapy.
    Yamaguchi E; Yamato K; Miyata Y
    J Hematother Stem Cell Res; 2000 Aug; 9(4):565-72. PubMed ID: 10982257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy.
    Arat M; Arslan O; Gürman G; Dalva K; Ozcan M; Uğur A; Ilhan O
    Transfus Apher Sci; 2004 Feb; 30(1):9-15. PubMed ID: 14746816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor.
    Schwartzberg LS; Birch R; Hazelton B; Tauer KW; Lee P; Altemose R; George C; Blanco R; Wittlin F; Cohen J
    J Hematother; 1992; 1(4):317-27. PubMed ID: 1285381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
    Cesana C; Carlo-Stella C; Regazzi E; Garau D; Sammarelli G; Caramatti C; Tabilio A; Mangoni L; Rizzoli V
    Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
    Hohaus S; Goldschmidt H; Ehrhardt R; Haas R
    Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
    Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
    Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells.
    Knudsen LM; Gaarsdal E; Jensen L; Nielsen KJ; Nikolaisen K; Johnsen HE
    J Hematother; 1996 Aug; 5(4):399-406. PubMed ID: 8877715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood progenitor cell mobilization in healthy donors receiving recombinant human granulocyte colony-stimulating factor.
    Carlo-Stella C; Cesana C; Regazzi E; Falzetti F; Aversa F; Rizzoli V; Martelli M; Tabilio A
    Exp Hematol; 2000 Feb; 28(2):216-24. PubMed ID: 10706078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.
    Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J
    Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.